Related references
Note: Only part of the references are listed.Current Status of Endoscopic Surgery in Japan: The 15th National Survey of Endoscopic Surgery by the Japan Society for Endoscopic Surgery
Hidefumi Shiroshita et al.
ASIAN JOURNAL OF ENDOSCOPIC SURGERY (2022)
The gut microbiota composition in patients with right- and left-sided colorectal cancer and after curative colectomy, as analyzed by 16S rRNA gene amplicon sequencing
Daisuke Suga et al.
BMC GASTROENTEROLOGY (2022)
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
Yojiro Hashiguchi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial
Zhidong Gao et al.
ANNALS OF SURGERY (2020)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prominent Information of jN3 Positive in Stage III Colorectal Cancer Removed by D3 Dissection: Retrospective Analysis of 6866 Patients From a Multi-institutional Database in Japan
Eiji Shinto et al.
DISEASES OF THE COLON & RECTUM (2018)
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes
Jonathan M. Loree et al.
CLINICAL CANCER RESEARCH (2018)
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer A Systematic Review and Meta-analysis
Fausto Petrelli et al.
JAMA ONCOLOGY (2017)
Safety, quality and effect of complete mesocolic excision vs non-complete mesocolic excision in patients with colon cancer: a systemic review and meta-analysis
C. Wang et al.
COLORECTAL DISEASE (2017)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
Microbiota disbiosis is associated with colorectal cancer
Zhiguang Gao et al.
FRONTIERS IN MICROBIOLOGY (2015)
Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
E. Missiaglia et al.
ANNALS OF ONCOLOGY (2014)
BRAF Mutations in Colorectal Cancer Are Associated With Distinct Clinical Characteristics and Worse Prognosis
Matthew F. Kalady et al.
DISEASES OF THE COLON & RECTUM (2012)
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
American Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
Carmen J. Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer
H Kobayashi et al.
SURGERY (2006)
Number versus distribution in classifying regional lymph node metastases from colon cancer
J Hida et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer
JC Kim et al.
EJSO (2004)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Colorectal cancer staging: Reappraisal of N/PN classification
CA Vaccaro et al.
DISEASES OF THE COLON & RECTUM (2004)
Prognostic determinants of patients with lateral nodal involvement by rectal cancer
H Ueno et al.
ANNALS OF SURGERY (2001)
Share Paper
